| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Skin-depigmenting agent monobenzone induces potent T-cell autoimmunity toward pigmented cells by tyrosinase haptenation and melanosome autophagy. | J Invest Dermatol | 2011 | 1.71 |
| 2 | Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. | J Invest Dermatol | 2009 | 1.56 |
| 3 | T-cell immune function in tumor, skin, and peripheral blood of advanced stage melanoma patients: implications for immunotherapy. | Clin Cancer Res | 2011 | 0.92 |
| 4 | Effective melanoma immunotherapy in mice by the skin-depigmenting agent monobenzone and the adjuvants imiquimod and CpG. | PLoS One | 2010 | 0.88 |